Document Classification

Section Type: RESULTS

Text: For the active treatment versus placebo group, the following pre - and post-treatment values, and significances for treatment effect comparisons, were respectively seen : cumulative vertigo scores, 22. 47 and 15. 97 vs 20. 42 and 19. 23 (p = 0. 048) ; vertigo days, 6. 5 and 4. 08 vs 5. 94 and 5. 52 (p = 0. 102) ; sick days, 3. 08 and 0. 78 vs 2. 87 and 3. 45 (p = 0. 041) ; vertigo-free days, 14. 47 and 17. 61 vs 15. 48 and 17. 58 (p = 0. 362) ; activity score, 23. 61 and 13. 42 vs 24. 68 and 20. 23 (p = 0. 078) ; low-tone hearing threshold, 49. 15 and 53. 18 dB nHL vs 41. 66 and 46. 10 dB nHL (p > 0. 05) ; and slow phase velocity in response to caloric stimulation, 18. 86 and 18. 72 / second vs 14. 97 and 15. 95 / second, (p > 0. 05).